CCNE1 is a predictive and immunotherapeutic indicator in various cancers including UCEC: a pan-cancer analysis
2023 · Hereditas · 16 citations
https://doi.org/10.1186/s41065-023-00273-0
S
Shuangshuang Zhao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
886
Citations
14
h-index
16
i10-index
Shuangshuang Zhao is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Endometrial and Cervical Cancer Treatments & Liver physiology and pathology. The author has an h-index of 14, co-authored 24 publications.
ORCID: 0000-0002-9930-0534Papers by this author
worksAnlotinib alone or in combination with bevacizumab in the treatment of recurrent high-grade glioma: a prospective single-arm, open-label phase II trial
2024 · BMC Cancer · 11 citations
https://doi.org/10.1186/s12885-023-11776-4
Liver transplantation: a test of cellular physiology, preservation and injury
2024 · Physiology · 2 citations
https://doi.org/10.1152/physiol.00020.2024
Author Correction: A comprehensive analysis and experimental validation of TK1 in uterine corpus endometrial carcinoma
2024 · Scientific Reports · 1 citations
https://doi.org/10.1038/s41598-024-59542-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat